XML 32 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENT OF CASH FLOWS
¥ in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2015
USD ($)
Dec. 31, 2015
CNY (¥)
Dec. 31, 2014
CNY (¥)
Dec. 31, 2013
CNY (¥)
Cash flows from operating activities        
Net income $ 26,440 ¥ 171,278 ¥ 66,911 ¥ 62,018
Adjustments to reconcile net income to net cash from operating activities        
Depreciation of property and equipment 3,958 25,636 21,684 11,702
Amortization of intangible assets 18,605 120,521 57,066 14,178
Provision for doubtful accounts 1,982 12,842 5,441 11,232
Impairment of goodwill and intangible assets 7,700 49,882 8,304  
Impairment of investments 5,361 34,728 9,136  
Loss on disposal of property and equipment 147 955    
(Gain) Loss on disposal of intangible assets 547 3,539   (3,600)
Gain on disposal/deemed disposal of equity method investments (6,866) (44,483)    
Settlement and changes in fair value of contingent considerations (1,082) (7,010) 13,749 1,067
Changes in fair value of redemption right and put options granted (3) (22) (4,375) (11,146)
Deemed employee compensation attributable to redemption right granted to a non-controlling shareholder       14,697
Losses from equity method investments 1,441 9,334 5,447 1,849
(Gain) Loss on disposal of an available-for-sale security 31 202 (1,967)  
Deferred income tax expenses (benefits) (1,075) (6,962) 12,906 33,910
Share-based compensation expenses 48,690 315,407 173,274 37,396
Adjustments to reconcile net income to net cash from operating activities, total 105,876 685,847 367,576 173,303
Changes in operating assets and liabilities        
Restricted cash (58) (378)    
Accounts receivable (48,805) (316,152) (151,979) (55,867)
Prepayments and other current assets (25,030) (162,139) (85,484) (45,433)
Due from related parties (3,012) (19,508) (30,702) 4,630
Other long-term assets 63 408 (15,917) (1,665)
Accounts payable 4,586 29,705 38,354 12,487
Accrued expenses and other payables 98,295 636,738 225,374 97,115
Deferred revenue 2,309 14,958 29,608 (4,258)
Due to related parties 5,466 35,405 (2,008) 5,023
Income tax payable 3,270 21,183 (8,995) 11,974
Other non-current liabilities 1,684 10,909 (4,385) 872
Net cash provided by operating activities 144,644 936,976 361,442 198,181
Cash flows from investing activities        
Purchase of property and equipment (9,431) (61,090) (36,169) (27,641)
Purchase of intangible assets (5,340) (34,590) (144,896) (2,359)
Purchase of cost method investments (61,676) (399,522) (157,304)  
Purchase of available-for-sale securities     (110,774) (36,582)
Purchase of equity method investments (16,538) (107,131) (125,739) (4,400)
Purchase of fixed-rate time deposits (74,286) (481,207) (1,388,167) (105,000)
Acquisition of business, net of cash acquired (38,505) (249,425) (195,199) (52,785)
Proceeds from sales of property and equipment 76 490 100 74
Proceeds from sales of Intangible assets 513 3,320    
Proceeds from sales of available-for-sale securities     17,076  
Proceeds from maturity of available-for-sale securities 10,522 68,162    
Proceeds from sales of equity method investments 2,007 13,000    
Maturity of fixed-rate time deposits 139,147 901,364 959,837 145,376
Entrusted loan to an investor of an equity investee       (14,000)
Entrusted loan to a third party (463) (3,000)    
Repayment of an entrusted loan from a third party     1,000  
Repayment of an entrusted loan from an investor of an equity investee 1,389 9,000 4,940 5,060
Repayment of loans to investors of an equity investee       (5,530)
Settlement of contingent consideration       (3,000)
Net cash used for investing activities (52,585) (340,629) (1,175,295) (100,787)
Cash flows from financing activities        
Proceeds from issuance of Series B Preferred Shares, net of issuance costs       321,965
Net of proceeds from the initial public offering ("IPO") and concurrent private placement     1,409,177  
Proceeds from exercise of restricted shares with an option feature 632 4,092 2  
Proceeds from bank loans 15,726 101,866    
Cash received from noncontrolling shareholder 521 3,375 6,750  
Distribution to a shareholder due to common control acquisition     (30,775) (17,693)
Settlement of contingent consideration (4,277) (27,706) (4,265)  
Net cash provided by financing activities 12,602 81,627 1,380,889 304,272
Effect of exchange rate changes on cash and cash equivalents 5,871 38,029 (4,287) (5,506)
Net increase in cash and cash equivalents 110,532 716,003 562,749 396,160
Cash and cash equivalents at beginning of period 168,774 1,093,285 530,536 134,376
Cash and cash equivalents at end of period 279,306 1,809,288 1,093,285 530,536
Supplemental disclosures        
Income taxes paid (3,412) (22,105) (20,410) (3,329)
Interest expense paid (84) (547)    
Non-cash investing and financing activities:        
Capital injection to an equity investee by intangible assets       3,600
Acquisition of property and equipment included in accrued expenses and other current liabilities 6,752 43,740 755  
Acquisition of an cost method investment included in accrued expenses and other liabilities 788 5,104    
Acquisition of an equity method investment included in accrued expenses and other liabilities 501 3,247    
Contingent considerations payable included in other non-current liabilities 3,603 23,338 53,592 ¥ 11,974
Non-cash acquisition of an equity method investment     ¥ 5,000  
Non-cash acquisition of an cost method investment 9,897 64,110    
Non-cash acquisition of business $ 3,598 ¥ 23,309